Actym Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Actym Therapeutics

Access the complete profile.

Actym Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	54133 Engineering Services
Address	626 Bancroft Way Suite A Berkeley, CA 94710

Note: Revenues for privately held companies are statistical evaluations.


Actym Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Actym Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Actym Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Actym Therapeutics Annual Revenue and Growth Rate

Actym Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Actym Therapeutics's revenues are gauged from an analysis of company filings.

Actym Therapeutics's Income Statement (based on Industry Averages)

Actym Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Actym Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
July 6, 2023	5	41%	$28 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Actym Therapeutics is developing and marketing. Actym Therapeutics doesn't have any recent trademark applications, indicating Actym Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
STACT Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer	07/18/2017

See all trademarks and details in the Full Report.

Market Share of Actym Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Actym Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Actym Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
TWELVE BENEFIT	Berkeley, CA	100
PIVOT BIO	Berkeley, CA	75
UPSIDE FOODS	Berkeley, CA	32
BIOSOLUTIONS	Berkeley, CA	7
RENEGADEXBIO PBC	Berkeley, CA	7
RIPPLE FOODS PBC	Berkeley, CA	7

Other Companies at 626 Bancroft Way, Berkeley CA

Company	Headquarters	Revenue ($ MM)
CHINOOK THERAPEUTICS	Berkeley, CA	100
OVID RESEARCH	Berkeley, CA	23
POLYSPECTRA	Albany, CA	11
CHAMELEON BIOSCIENCES	Albany, CA	9
CORRELIA BIOSYSTEMS	Berkeley, CA	5

Future Competition: Actym Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Actym Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)